Stephan Dirnhofer
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals
Conconi A, Bernasconi E, Bertoni F, Gaidano G, Cavalli F, Nassi L, Kwee I, Dirnhofer S, Scherrer A, Schmid P, Novak U, Staehelin C, Battegay M, Hasse B, Darling K, Margiotta-Casaluci G, Zucca E, Swiss HIV Cohort Study (SHCS). Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. Hematol Oncol 2018
Aug 16, 2018Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals
Aug 16, 2018Hematol Oncol 2018
Conconi Annarita, Bernasconi Enos, Bertoni Francesco, Gaidano Gianluca, Cavalli Franco, Nassi Luca, Kwee Ivo, Dirnhofer Stephan, Scherrer Alexandra, Schmid Patrick, Novak Urban, Staehelin Cornelia, Battegay Manuel, Hasse Barbara, Darling Katharine, Margiotta-Casaluci Gloria, Zucca Emanuele, Swiss HIV Cohort Study (SHCS)
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
Mamot C, Zucca E, Dirnhofer S, Rusterholz C, Biaggi C, Samarin A, Hany T, Gigli F, Krasniqi F, Bargetzi M, Pless M, Mey U, Driessen C, Pabst T, Renner C, Hitz F, Klingbiel D, Martinelli G. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07). J Clin Oncol 2015; 33:2523-9.
Jul 6, 2015Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
Jul 6, 2015J Clin Oncol 2015; 33:2523-9
Mamot Christoph, Zucca Emanuele, Dirnhofer Stephan, Rusterholz Corinne, Biaggi Christine, Samarin Andrei, Hany Thomas, Gigli Federica, Krasniqi Fatime, Bargetzi Mario, Pless Miklos, Mey Ulrich, Driessen Christoph, Pabst Thomas, Renner Christoph, Hitz Felicitas, Klingbiel Dirk, Martinelli Giovanni
Granulomas are a source of interleukin-33 expression in pulmonary and extrapulmonary sarcoidosis
Kempf W, Zollinger T, Sachs M, Ullmer E, Cathomas G, Dirnhofer S, Mertz K. Granulomas are a source of interleukin-33 expression in pulmonary and extrapulmonary sarcoidosis. Hum Pathol 2014; 45:2202-10.
Jul 31, 2014Granulomas are a source of interleukin-33 expression in pulmonary and extrapulmonary sarcoidosis
Jul 31, 2014Hum Pathol 2014; 45:2202-10
Kempf Werner, Zollinger Therese, Sachs Melanie, Ullmer Elke, Cathomas Gieri, Dirnhofer Stephan, Mertz Kirsten D
Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial.
Bucher C, Lehmann T, Tichelli A, Tzankov A, Dirnhofer S, Passweg J, Rovó A. Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial. J Clin Pathol 2012; 66:24-8.
Oct 26, 2012Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial.
Oct 26, 2012J Clin Pathol 2012; 66:24-8
Bucher Christoph, Lehmann Thomas, Tichelli André, Tzankov Alexander, Dirnhofer Stephan, Passweg Jakob, Rovó Alicia
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.
Girsberger S, Karow A, Lundberg P, Dirnhofer S, Lehmann T, Passweg J, Tichelli A, Skoda R, Rovó A. JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report. Acta Haematol 2012; 129:23-5.
Sep 19, 2012JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.
Sep 19, 2012Acta Haematol 2012; 129:23-5
Girsberger Sabine, Karow Axel, Lundberg Pontus, Dirnhofer Stephan, Lehmann Thomas, Passweg Jakob R, Tichelli André, Skoda Radek C, Rovó Alicia
Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas
Hoeller S, Tzankov A, Hirschmann P, Foerster A, Went P, Zettl A, Ponzoni M, Cogliatti S, Zihler D, Bihl M, Dirnhofer S. Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas. Hum Pathol 2011; 43:405-12.
Aug 19, 2011Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas
Aug 19, 2011Hum Pathol 2011; 43:405-12
Hoeller Sylvia, Tzankov Alexandar, Hirschmann Petra, Foerster Anja, Went Philip, Zettl Andreas, Ponzoni Maurilio, Cogliatti Sergio B., Zihler Deborah, Bihl Michel P, Dirnhofer Stephan
Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
Craig V, Tzankov A, Dirnhofer S, Schlapbach R, Rehrauer H, Neuenschwander S, Renner C, Imig J, Cogliatti S, Müller A. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood 2011; 117:6227-36.
Apr 1, 2011Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
Apr 1, 2011Blood 2011; 117:6227-36
Craig Vanessa J, Tzankov Alexander, Dirnhofer Stephan, Schlapbach Ralph, Rehrauer Hubert, Neuenschwander Stefan, Renner Christoph, Imig Jochen, Cogliatti Sergio B., Müller Anne
Precursor B lymphoblastic leukemia 32 months after local therapy for a primary extramedullary myeloid cell tumor
Szinnai G, Cogliatti S, Avoledo P, Dirnhofer S, Schmid U, Kühne T. Precursor B lymphoblastic leukemia 32 months after local therapy for a primary extramedullary myeloid cell tumor. Pediatr Blood Cancer 2007; 49:1039-46.
Dec 1, 2007Precursor B lymphoblastic leukemia 32 months after local therapy for a primary extramedullary myeloid cell tumor
Dec 1, 2007Pediatr Blood Cancer 2007; 49:1039-46
Szinnai Gabor, Cogliatti Sergio B., Avoledo Pierino, Dirnhofer Stephan, Schmid Ulrico, Kühne Thomas
Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia
Lugli A, Tichelli A, Von Juergensonn S, Mach-Pascual S, Borisch B, Tinguely M, Hawle H, Korte W, Hess U, Passweg J, Gratwohl A, Cogliatti S, Ebnoether M, Dirnhofer S. Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia. Hum Pathol 2005; 36:91-100.
Jan 1, 2005Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia
Jan 1, 2005Hum Pathol 2005; 36:91-100
Lugli Alessandro, Tichelli André, Von Juergensonn Silke, Mach-Pascual Sara, Borisch Bettina, Tinguely Marianne, Hawle Hanne, Korte Wolfgang, Hess Urs, Passweg Jakob, Gratwohl Alois, Cogliatti Sergio B., Ebnoether Monika, Dirnhofer Stephan